The global Pathogen Market is expected to reach USD 12.2 billion by 2034, fueled by increasing infectious disease outbreaks, rapid pathogen detection technologies, molecular diagnostics, and growing investments in biosurveillance systems. Rising demand for PCR testing, AI-powered diagnostics, food safety monitoring, and antimicrobial resistance management is accelerating market growth across healthcare and biotechnology sectors globally.